Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01611701 · ClinicalTrials.gov registry record · Phase 3
Cryoballoon Ablation of Pulmonary Veins After Failed RF Ablation in Patients With Paroxysmal AF
A Phase 3 study, sponsored by Meshalkin Research Institute of Pathology of Circulation.
- Completed
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
NCT01611701 is a Phase 3 study that has completed, run by Meshalkin Research Institute of Pathology of Circulation. The registered enrollment target is 80 participants.
The verdict
NCT01611701, a Phase 3 study, has completed, sponsored by Meshalkin Research Institute of Pathology of Circulation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
Study Summary
The aim of this prospective randomized double-blind study was to compare the efficacy and safety of cryoballoon ablation with the RF approach in the treatment of paroxysmal AF after failed first radiofrequency ablation.
Interventions
- PROCEDURE Radiofrequency ablation
- PROCEDURE cryoballoon ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01611701
The ClinicalTrials.gov registry entry for NCT01611701 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Meshalkin Research Institute of Pathology of Circulation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Radiofrequency ablation is the first listed.
NCT01611701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01611701 about?
NCT01611701 is a clinical study titled "Cryoballoon Ablation of Pulmonary Veins After Failed RF Ablation in Patients With Paroxysmal AF". The aim of this prospective randomized double-blind study was to compare the efficacy and safety of cryoballoon ablation with the RF approach in the treatment of paroxysmal AF after failed first radiofrequency ablation.
What is the current status of trial NCT01611701?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2009-10. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01611701?
The interventions under investigation include: Radiofrequency ablation (PROCEDURE), cryoballoon ablation (PROCEDURE).
Who is sponsoring clinical trial NCT01611701?
This trial is sponsored by Meshalkin Research Institute of Pathology of Circulation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.